Healthcare

This Senate resolution officially designates May 2026 as Lupus Awareness Month in California to highlight the chronic autoimmune disease that affects 1.5 million people in the United States. The bill specifically commends the California Lupus Foundation for its long-standing efforts in providing support, education, and medical care resources to patients and their families. By recognizing the foundation's leadership, the resolution aims to increase public understanding of the disease's symptoms and the importance of early diagnosis. This measure serves as a symbolic gesture rather than establishing new laws or funding requirements.

This bill designates May 2026 as Maternal Mental Health Awareness Month to highlight the importance of mental health support for mothers. It serves as a symbolic proclamation rather than a law that changes regulations or imposes new requirements. The measure directly affects state officials who will recognize the month and may encourage public awareness campaigns during that time.

Existing law, the Sherman Food, Drug, and Cosmetic Law, under the administration and enforcement of the State Department of Public Health, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics. Existing law places product testing and disclosure requirements on various products, including baby food and prenatal vitamins. A violation of the Sherman Food, Drug, and Cosmetic Law is punishable as a misdemeanor. This bill would, commencing January 1, 2028, require a manufacturer of a bulk protein product or a packaged protein product, as defined, that is sold, manufactured, delivered, held, or offered for sale in this state to test a representative sample of each lot of the product for heavy metals, as defined. The bill would require both a manufacturer and brand owner to provide test results to an authorized agent of the department upon their request, as specified. The bill would, commencing January 1, 2028, require a brand owner of a packaged protein product that is sold, manufactured, delivered, held, or offered for sale in the state to disclose specified product information to the public, including, among other things, the heavy metal testing information. Commencing on or after January 1, 2028, the bill would require a statement regarding heavy metal testing to be included on the outermost package of a packaged protein product sold in a retail store and on the product details page on an internet website for products sold online or directly to consumers. The bill would, commencing January 1, 2028, prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state a protein product that does not comply with these provisions. By creating a new crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

This Senate Resolution designates the week of May 10 to May 16, 2026, as Hospital Week in California to honor the state's hospitals and their staff. The measure recognizes the vital role hospitals play in providing care, training medical professionals, and supporting the local economy across rural, suburban, and urban areas. By officially acknowledging these institutions, the resolution aims to highlight their importance during National Hospital Week without changing any laws or policies.

This bill designates April 2026 as Parkinson's Disease Awareness Month in California. It directly affects state officials and the public by formally recognizing the importance of raising awareness for this specific health condition. The primary mechanism is a legislative proclamation that appears in the state statutes to mark the month. This action serves as an official acknowledgment of the disease without changing laws or funding.

This Senate Resolution designates May 2026 as Amyotrophic Lateral Sclerosis Awareness Month in California to highlight the challenges faced by individuals with ALS, also known as Lou Gehrig's disease. The measure calls on the public and government officials to support research funding, advocate for better access to medical equipment, and stand in solidarity with patients and their families. While the resolution does not change laws or allocate specific funds, it serves to raise awareness about the disease's impact and the need for continued clinical trials and treatment development.

Senate Resolution 103 designates the first full week in May 2026 as Tardive Dyskinesia Awareness Week in California. This proclamation aims to raise public and medical awareness about tardive dyskinesia, a movement disorder that can occur in people taking antipsychotic medications for mental health conditions. The resolution emphasizes the importance of early detection and routine screening for this condition, which affects a significant portion of patients who may be undiagnosed. By highlighting these issues, the bill encourages healthcare providers and patients to prioritize regular check-ups and education regarding the risks and symptoms associated with long-term antipsychotic use.

This measure would designate the week of March 15, 2026, to March 21, 2026, inclusive, as Family Physician Week, recognize the invaluable contributions of family physicians to California's health care system, and encourage continued investment in primary care to strengthen the family medicine workforce.

Senate Resolution 89 designates March 17, 2026, as Profound Autism Day in California to raise awareness for individuals with severe autism who require 24-hour care. The resolution highlights the historical context of autism classification and notes that current research and support systems often overlook those with the most intensive needs. By recognizing this specific day, the Senate aims to encourage increased research, improved services, and greater dignity for people living with profound autism.

This measure would designate February 28, 2026, as Rare Disease Day and, with respect to rare diseases and disorders, would recognize the importance of improving awareness, encouraging accurate and early diagnosis, and supporting national and global efforts to develop effective treatments, diagnostics, and cures.